PRESSEFACH
WEITERE ADHOC-MELDUNGEN
SHF Communication Technologies AG hebt Umsatz- und Ergebnisprognose für das Geschäftsjahr 2018 an
SHF Communication Technologies AG beschließt Delisting ihrer Aktien
Mitteilung über Eigengeschäfte von Führungskräften gem. Art. 19 MAR
China kommt zu RENÉ LEZARD
Umsatzwachstum im ersten Halbjahr von 31,8% - Halbjahresumsatz beträgt 149 Mio. Euro
KFM-Mittelstandsanleihen-Barometer - Die "6,00%-FCR Immobilien-Anleihe"
Kapitalerhöhung
 
MELDUNG VOM 02.01.2018 11:15
Meldung drucken Artikel weiterleiten
pta20180102008
Release according to article 40 para. 1 WpHG
Pressefach Pressefach

Medigene AG: Correction of a Release according to Article 26, Section 1 of the WpHG from 22.12.2017

Voting Rights Announcement according to §§ 21 ff WpHG

Planegg (pta008/02.01.2018/11:15) - Release of Voting Rights Announcement

Correction of a notification of Major Holding published on 22.12.2017

1. Details of issuer:
Medigene AG, Lochhamer Straße 11, 82152 Planegg, Germany

2. Reason for notification:
Acquisition / disposal of shares with voting rights

3. Details of person subject to the notification obligation
Name: Aviva plc.
City and country of registered office: London, United Kingdom

4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3
Aviva Life & Pensions UK Limited

5. Date on which threshold was crossed or reached
19.12.2017

6. Total positions

% of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) total of both in % (7.a. + 7.b.) total number of voting rights of issuer
Resulting situation 4.96 1.58 6.54 22,300,947
Previous notification 5,04 1,52 6,56

7. Notified details of the resulting situation

a. Voting rights attached to shares (Sec.s 33, 34 WpHG)

ISIN absolute direct (Sec. 33 WpHG) absolute indirect (Sec. 34 WpHG) in % direct (Sec. 33 WpHG) in % indirect (Sec. 34 WpHG)
DE000A1X3W00 0 1,105,767 0.00 4.96
Total: 1,105,767 4.960000

b.1. Instruments according to Sec. 38 para. 1 No. 1 WpHG

Type of instrument Maturity / Expiration Exercise or conversion period Voting Rights Absolute Voting Rights in %
Right to recall loaned shares N/A N/A 352,908 1.58
Total: 352,908 1.580000

b.2 Instruments according to Sec. 38 para. 1 No. 2 WpHG

Type of instrument Maturity / Expiration Exercise or conversion period Cash or physical transaction Voting Rights Absolute Voting Rights in %
Total:

8. Information in relation to the person subject to the notification obligation

Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity

Name % of voting rights if 3% or higher % of voting rights through instruments if 5% or higher Total of both if 5% or higher
Aviva plc
Aviva Group Holdings Limited
Aviva France SA
--
Aviva plc
Aviva Group Holdings Limited
Aviva Life Holdings UK Limited
Aviva Life & Pensions UK Limited 3.21
--
Aviva plc
Aviva Group Holdings Limited
Aviva Investors Holdings Limited
Aviva Investors Luxembourg SA
--
Aviva plc
Aviva Group Holdings Limited
Aviva Investors Holdings Limited
Aviva Investors Global Services Limited 4.96 6.54
--
Aviva plc
Aviva Group Holdings Limited
Aviva Investors Holdings Limited
Friends Life Funds Limited

9. In case of proxy voting according to § 34 para. 3 WpHG

Date of general meeting: N/A

10. Other useful information

(Ende)

Aussender: Medigene AG
Lochhamer Straße 11
82152 Planegg
Deutschland
Ansprechpartner: Medigene PR/IR
Tel.: +49 89 2000 33 3301
E-Mail:
Website: www.medigene.de
ISIN(s): DE000A1X3W00 (share)
Börsen: regulated market in Frankfurt; free market in Dusseldorf, free market in Hamburg, free market in Hannover, free market in Munich, free market in Stuttgart; open market in Berlin, Tradegate
Medigene AG